Trial intelligence / Profile preview

Steroid-sparing effect of combined nasal and inhaled corticosteroids in asthma with persistent rhinitis

2005-005531-99Phase 4Completed

Sponsor: University of Dundee
Start: Mar 2006
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4, randomised, double-blind trial in asthma and allergic rhinitis (AR) comparing High-dose inhaled fluticasone + intranasal placebo with Low-dose inhaled fluticasone + nasal fluticasone (2 arms). Primary endpoint: Primary outcome: Methacholine PC20 bronchial hyperresponsiveness. Started Mar 2006; status: completed.

Drugs

fluticasone

Conditions

asthmaallergic rhinitis (AR)

Beyond the preview

Go deeper on 2005-005531-99.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005531-99.